Clinical Trial Update: The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination

View source ↗

Summary

A clinical trial evaluating the cardiovascular effects of a GLP-1 receptor agonist, an SGLT2 inhibitor, and their combination in adults with Type 2 diabetes mel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonist
• SGLT2 inhibitor

Snippet

Sponsor: University of Athens | Conditions: Diabetes Mellitus, Type 2 | Status: RECRUITING